CAY10677

CAY10677

CAT N°: 14744
Price:

From 80.00 68.00

Post-translational protein prenylation is a 3-step process that occurs at the C-terminus of a number of proteins involved in cell growth control and oncogenesis. Isoprenylcysteine carboxyl methyltransferase (Icmt) catalyzes the methylation of C-terminal prenylcysteine residues, the last step in this process. CAY10677 is an analog of the Icmt inhibitor cysmethynil (Item No. 14745) that was developed for improved solubility and cell permeability.{23335} CAY10677 inhibits Icmt with an IC50 value of 0.86 ?M and demonstrates nearly 10-fold more potent antiproliferative activity than cysmethynil on human breast cancer MDA-MB-231 cells (IC50s = 2.63 versus 27.4 ?M, respectively) and human prostate cancer PC3 cells (IC50s = 2.55 versus 25.2 ?M, respectively).{23335}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 5-(2-amino-5-pyrimidinyl)-N,N-diethyl-1-octyl-1H-indole-3-methanamine
  • Correlated keywords
    • post-translational post translations posttranslations proteins prenylation cancers Isoprenylcysteine carboxyl methyltransferase analogs Icmt inhibitors cysmethynil antiproliferative inhibits inhibitions CAY-10677 CAYs 10677 anti-proliferative anti proliferative breasts MDA-MB-231 cells prostate PC3 signals transductions intracellular signaling c-terminus growth oncogenesis methylation prenylcysteine protein lipidation
  • Product Overview:
    Post-translational protein prenylation is a 3-step process that occurs at the C-terminus of a number of proteins involved in cell growth control and oncogenesis. Isoprenylcysteine carboxyl methyltransferase (Icmt) catalyzes the methylation of C-terminal prenylcysteine residues, the last step in this process. CAY10677 is an analog of the Icmt inhibitor cysmethynil (Item No. 14745) that was developed for improved solubility and cell permeability.{23335} CAY10677 inhibits Icmt with an IC50 value of 0.86 ?M and demonstrates nearly 10-fold more potent antiproliferative activity than cysmethynil on human breast cancer MDA-MB-231 cells (IC50s = 2.63 versus 27.4 ?M, respectively) and human prostate cancer PC3 cells (IC50s = 2.55 versus 25.2 ?M, respectively).{23335}

We also advise you